Developer docs
API playgroundTry for free, no card

Search company profiles

Technoclone

Full company profile

uuid002aykz

Namestring
Technoclone
Legal namestring
Technoclone Herstellung von Diagnostika und Arzneimitteln GmbH
Websiteurl
technoclone.com
Company typeenum
Private
Founded yearint
1987
Descriptiontext

Technoclone Herstellung von Diagnostika und Arzneimitteln GmbH is a Vienna-based, privately held in vitro diagnostics company founded in 1987 by Prof. Dr. Bernd R. Binder. The company specializes in coagulation and fibrinolysis diagnostics, manufacturing both instruments and reagents that clinical laboratories use to diagnose and monitor bleeding, thrombophilic, and anticoagulated patients. Its core technology stack combines proprietary ELISA systems (Actibind for simultaneous activity and antigen determination), the first CE-marked thrombin generation assays (Technothrombin TGA / Ceveron TGA), and the Ceveron analyzer platform — including the fully automated s100/t100/c100 series with the world's first quenching module for automated FXIII and ADAMTS13 testing, and the semi-automated m1/m2/m4 line.

The company's product portfolio spans the full hemostasis workflow: global coagulation tests (PT/aPTT/D-Dimer), factor assays, von Willebrand disease and TTP diagnostics (including FDA-cleared ADAMTS13), anticoagulant treatments including DOAC testing, thrombophilia and fibrinolysis markers, thrombin generation reagents, and research-only proteins and antibodies. Products are marketed under multiple sub-brands (Ceveron, TECHNOZYM, TECHNOLEIA, Technochrom, Technothrombin TGA, Actibind), creating distinct positioning across clinical and research use cases.

Technoclone operates a multi-channel go-to-market: a worldwide distributor network for clinical products, a dedicated direct sales operation in the UK, an OEM/private-label channel that supplies major international diagnostic companies with rebranded test systems, and a research-products catalog sold through its own website and academic partners. Regulatory positioning is a meaningful asset, with ISO 13485:2016, ISO 9001:2015, and MDSAP certifications (the latter enabling audit-efficient access to USA, Canada, Brazil, Japan, and Australia), CE-marking for EU clinical products, and FDA clearance for ADAMTS13 Activity. Pricing is quote-based rather than publicly disclosed, and the customer base spans clinical diagnostic laboratories, academic and research institutions, and OEM diagnostic manufacturers.

Short descriptiontext

Technoclone is a Vienna-based, privately held in vitro diagnostics company founded in 1987 that develops and manufactures coagulation and fibrinolysis tests, reagents, and automated analyzers (Ceveron series) for clinical laboratories, academic researchers, and OEM diagnostic partners worldwide.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersVienna, Austria
HQ citystring
Vienna
HQ countrystring
Austria
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
coagulation diagnostics, hemostasis analyzers, thrombin generation assays, fibrinolysis ELISA kits, in vitro diagnostics
Industry3 codes
PRIMARYHLAHAAAB
Hematology & Coagulation Diagnostics
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAGADAC
Release Testing & Batch Certification (QC)
SECONDARYHLAAALAH
Clinical Chemistry & Hematology Diagnostics (automated analyzers, blood testing)
NAICS code2 codes
  • In-Vitro Diagnostic Substance Manufacturing325413
  • Analytical Laboratory Instrument Manufacturing334516
SIC code2 codes
  • In Vitro & In Vivo Diagnostic Substances2835
  • Laboratory Analytical Instruments3826
Product category
Coagulation and Fibrinolysis Diagnostics
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Diagnostic Tests and Reagents
TypeHardware Sales
Description

Technoclone manufactures and sells diagnostic tests for coagulation and fibrinolysis including ELISA kits, latex immunoassays, and chromogenic assays. Products include D-Dimer tests, coagulation factor assays, fibrinolysis markers (t-PA, u-PA, PAI-1), and specialized tests like ADAMTS13 activity.

technoclone.com
2Coagulation Instruments
TypeHardware Sales
Description

Sale of automated and semi-automated coagulation analyzers (Ceveron series: s100, t100, c100, m1, m2, m4, MFU500) along with consumables, cuvettes, reagents, and accessories.

technoclone.com
3OEM Products
TypeLicensing Royalties
Description

High-quality test systems and reagents manufactured by Technoclone are sold not only under the Technoclone name worldwide but also as OEM products with major international diagnostic companies.

technoclone.com
4Research Products
TypeOne Time License
Description

Sale of research-use-only products including fibrinolysis-related proteins and antibodies for research purposes.

technoclone.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
Pricing details1 tier
1Product catalogue available for download; specific pricing requires inquiry
ModelOtherBilling cadenceMulti-year contract
Notes

Product catalogue available for download. Direct contact required for pricing on diagnostic tests, instruments, and reagents. UK direct sales contact: supportuk@technoclone.com

technoclone.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 6 records shown
1Ceveron
Description

Fully and semi-automated coagulation analyzers for clinical diagnostics including Ceveron s100, t100, c100, and m-series instruments

technoclone.com
+5 more records
Core offering1 text field

Technoclone manufactures and sells in vitro diagnostic tests, automated and semi-automated coagulation analyzers (Ceveron series), and research-use reagents for the diagnosis and monitoring of hemostasis (blood clotting) and fibrinolysis disorders. Its product range covers routine coagulation assays, specialized thrombin generation tests, fibrinolysis ELISA panels, D-Dimer testing, and supporting auxiliary reagents, sold to clinical laboratories, hospitals, research institutions, and OEM diagnostic partners worldwide.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Technoclone is a Vienna-based diagnostics company founded in 1987 specializing in in vitro diagnostics for hemostasis and fibrinolysis. The product portfolio centers on the Ceveron instrument family (fully automated 100 Series: c100, t100, s100; semi-automated m Series: m1, m2, m4; and MFU500 filtration unit) and a comprehensive range of diagnostic reagents and assays. The Ceveron 100 Series instruments offer fully automated coagulation testing including clotting, chromogenic, turbidimetric assays, and thrombin generation (TGA), with the s100 model additionally featuring quenching technology for automated FXIII and ADAMTS13 activity testing. The company offers Technothrombin TGA reagents for microplate readers (RUO) and Ceveron TGA Kits (CE-marked) for automated instruments. Diagnostic assays include D-Dimer testing (TECHNOLEIA), fibrinolysis panels (TECHNOZYM ELISAs for t-PA, PAI-1, u-PA, PAP Complex, Glu-Plasminogen, Protein C Inhibitor, t-PA-PAI-1 Complex), and Technochrom chromogenic assays for plasminogen and plasmin inhibitor. The portfolio also includes general and Ceveron-specific auxiliary reagents. Products are distributed globally under the Technoclone brand and as OEM products through other major diagnostic companies.

Product and service18 records
1Ceveron s100
CategoryAutomated Coagulation Analyzer
Description

Fully automated coagulation analyzer for clinical laboratories performing clotting, chromogenic, turbidimetric assays, TGA, and quenching assays; world's first fully automated hemostasis analyzer with quenching technology capable of automated FXIII and ADAMTS13 activity testing from a single sample.

2Ceveron t100
CategoryAutomated Coagulation Analyzer
Description

Fully automated coagulation analyzer for clotting, chromogenic, turbidimetric assays, and thrombin generation testing in clinical laboratories.

3Ceveron c100
CategoryAutomated Coagulation Analyzer
Description

Fully automated coagulation analyzer for clotting, chromogenic, and turbidimetric assays in clinical laboratories.

4Ceveron m1
CategorySemi-Automated Coagulation Analyzer
Description

Semi-automated coagulation analyzer with one optical channel (620nm), for whole blood and citrate plasma samples in clinical laboratories.

5Ceveron m2
CategorySemi-Automated Coagulation Analyzer
Description

Semi-automated coagulation analyzer with two optical channels at 405nm (UV), for citrate plasma samples in clinical laboratories.

6Ceveron m4
CategorySemi-Automated Coagulation Analyzer
Description

Semi-automated coagulation analyzer with four optical channels at 405nm (UV), for citrate plasma samples in clinical laboratories.

7Ceveron MFU500
CategorySample Preparation Instrument
Description

Microparticle Filtration Unit (MFU) 500 enabling quick and standardized removal of microparticles from platelet poor plasma, with effectiveness comparable to ultra-centrifugation.

8Ceveron TGA Kits
CategoryDiagnostic Reagent Kit
Description

CE-marked thrombin generation assay kits (RB, RC Low, RC High) optimized for Ceveron t100 and s100 instruments, measuring bleeding, thrombophilic, and anticoagulated tendencies.

9Technothrombin TGA
CategoryDiagnostic Reagent Kit
Description

Research-use-only thrombin generation reagents for fluorescence microplate readers, available in kit format with multiple triggers and as modular reagents (RA, RB, RC Low, RC High, IVIG, RD, SUB).

10TECHNOLEIA D-Dimer Latex Kit
CategoryDiagnostic Assay
Description

Latex-enhanced immunoassay for quantitative D-Dimer determination used in clinical laboratories for exclusion diagnosis of deep venous thrombosis, pulmonary embolism, DIC, thrombolytic treatment monitoring, and cancer diagnostics.

11TECHNOZYM t-PA EDTA ELISA Kit
CategoryDiagnostic Assay
Description

Sandwich ELISA kit for quantitative determination of tissue plasminogen activator (t-PA) in human plasma, detecting both complexed and uncomplexed forms.

12TECHNOZYM PAI-1 Antigen ELISA Kit
CategoryDiagnostic Assay
Description

Sandwich ELISA detecting active, latent, and t-PA-PAI-1 complex forms of plasminogen activator inhibitor-1 (PAI-1) in plasma.

13TECHNOZYM PAI-1 Actibind ELISA Kit
CategoryDiagnostic Assay
Description

Highly sensitive ELISA for quantitative determination of active PAI-1 antigen in human plasma based on Actibind functional t-PA immobilization technology.

14TECHNOZYM u-PA ELISA Kit
CategoryDiagnostic Assay
Description

Sandwich ELISA for quantitative determination of urokinase-type plasminogen activator (u-PA) in human plasma and tissue extracts, detecting both single and double chain urokinase.

15TECHNOZYM u-PA Combi Actibind ELISA Kit
CategoryDiagnostic Assay
Description

Combined ELISA using Actibind technology for simultaneous quantitative determination of u-PA concentration and activity in human plasma.

16TECHNOZYM PAP Complex ELISA Kit
CategoryDiagnostic Assay
Description

ELISA kit for determination of Plasmin-alpha-2-Antiplasmin complex (PAP) concentration in plasma, using a monoclonal antibody specific for the neoantigenic site on the complex.

17TECHNOZYM Glu-Plasminogen ELISA Kit
CategoryDiagnostic Assay
Description

Sandwich ELISA for selective quantitative determination of Glu-Plasminogen in human plasma using monoclonal antibodies specific for the native Glu-form.

18TECHNOZYM Protein C Inhibitor Actibind ELISA Kit
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

In 1998, Technoclone acquired the product portfolio of the former Immuno Diagnostika from Baxter AG, enabling rapid expansion and establishment as a global diagnostics company.

2OEM Diagnostic Partners
Strategic tierCoreTypeOEM/ Whitelabel/ Licensing Partner
Description

High-quality test systems and reagents manufactured by Technoclone are sold as OEM products with major international diagnostic firms, distributed under their own brand names.

technoclone.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research and development conducted in collaboration with universities and international and national research consortia in the field of thrombosis and cardiovascular diseases.

4ECTH (European Congress on Thrombosis and Haemostasis)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Since 2023, the BRB Award (Bernd R. Binder Publication Prize) has been part of the ECTH congress, bringing together researchers, scientists, clinicians, and other medical professionals for thrombosis and hemostasis education.

technoclone.com
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Specialty IVD company with a hemostasis product line including coagulation analyzers and reagents, comparable in scale and niche focus to Technoclone.

TypeEmerging player
Description

Niche coagulation research reagent supplier (proteins, antibodies) with a similar customer base to Technoclone's research products and fibrinolysis research offerings.

TypeDirect peer
Description

Privately held French company and a global leader in hemostasis diagnostics, offering automated coagulation analyzers and a comprehensive reagent menu closely overlapping Technoclone's Ceveron instruments and coagulation/fibrinolysis kits.

TypeDirect peer
Description

Specialized hemostasis division (IL) with the ACL TOP family of coagulation analyzers and broad specialty reagents, directly competing with Technoclone in routine and specialty coagulation testing for clinical labs.

TypeBroad incumbent
Description

Broad incumbent with cobas t-series coagulation analyzers and reagents, competing in routine hemostasis and increasingly in specialty assays relevant to Technoclone's portfolio.

TypeEmerging player
Description

Reference hemostasis reagent and analyzer partners in the coagulation specialty channel, adjacent peers that overlap in the fibrinolysis, TGA, and ADAMTS13 niches Technoclone targets.

TypeDirect peer
Description

Privately held specialty IVD company focused on hemostasis and thrombophilia testing, offering analyzers and reagents that directly compete with Technoclone's coagulation portfolio.

TypeBroad incumbent
Description

Broad incumbent with the Sysmex-derived hemostasis franchise (CA-series analyzers) and deep reagent portfolio, serving the same clinical labs as Technoclone but as part of a much wider diagnostics portfolio.

TypeBroad incumbent
Description

Major hematology and hemostasis analyzer vendor with a broad installed base; competes with Technoclone's Ceveron series in mid- and high-volume coagulation testing.

10Abbott (Diagnostics)
TypeBroad incumbent
Description

Broad incumbent with coagulation/immunoassay platforms (Architect, Alinity ci-series) that overlap with Technoclone's clinical laboratory customers and hemostasis test menu.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Technoclone

Coagulation and Fibrinolysis Diagnosticstechnoclone.com

Technoclone is a Vienna-based, privately held in vitro diagnostics company founded in 1987 that develops and manufactures coagulation and fibrinolysis tests, reagents, and automated analyzers (Ceveron series) for clinical laboratories, academic researchers, and OEM diagnostic partners worldwide.

What Technoclone does

Technoclone Herstellung von Diagnostika und Arzneimitteln GmbH is a Vienna-based, privately held in vitro diagnostics company founded in 1987 by Prof. Dr. Bernd R. Binder. The company specializes in coagulation and fibrinolysis diagnostics, manufacturing both instruments and reagents that clinical laboratories use to diagnose and monitor bleeding, thrombophilic, and anticoagulated patients. Its core technology stack combines proprietary ELISA systems (Actibind for simultaneous activity and antigen determination), the first CE-marked thrombin generation assays (Technothrombin TGA / Ceveron TGA), and the Ceveron analyzer platform — including the fully automated s100/t100/c100 series with the world's first quenching module for automated FXIII and ADAMTS13 testing, and the semi-automated m1/m2/m4 line.

The company's product portfolio spans the full hemostasis workflow: global coagulation tests (PT/aPTT/D-Dimer), factor assays, von Willebrand disease and TTP diagnostics (including FDA-cleared ADAMTS13), anticoagulant treatments including DOAC testing, thrombophilia and fibrinolysis markers, thrombin generation reagents, and research-only proteins and antibodies. Products are marketed under multiple sub-brands (Ceveron, TECHNOZYM, TECHNOLEIA, Technochrom, Technothrombin TGA, Actibind), creating distinct positioning across clinical and research use cases.

Technoclone operates a multi-channel go-to-market: a worldwide distributor network for clinical products, a dedicated direct sales operation in the UK, an OEM/private-label channel that supplies major international diagnostic companies with rebranded test systems, and a research-products catalog sold through its own website and academic partners. Regulatory positioning is a meaningful asset, with ISO 13485:2016, ISO 9001:2015, and MDSAP certifications (the latter enabling audit-efficient access to USA, Canada, Brazil, Japan, and Australia), CE-marking for EU clinical products, and FDA clearance for ADAMTS13 Activity. Pricing is quote-based rather than publicly disclosed, and the customer base spans clinical diagnostic laboratories, academic and research institutions, and OEM diagnostic manufacturers.

Technoclone firmographics

Firmographics
Name
Technoclone
Legal name
Technoclone Herstellung von Diagnostika und Arzneimitteln GmbH
Website
https://technoclone.com
Company type
Private
Founded year
1987
Operating status
Operating
Headcount range
11–50 employees
Short description
Technoclone is a Vienna-based, privately held in vitro diagnostics company founded in 1987 that develops and manufactures coagulation and fibrinolysis tests, reagents, and automated analyzers (Ceveron series) for clinical laboratories, academic researchers, and OEM diagnostic partners worldwide.
Ownership category
akta.pro rank

Technoclone industry classification

Industry
Product category
Coagulation and Fibrinolysis Diagnostics
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)
SIC
In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)
akta.pro industry
PRIMARYHLAHAAAB
Hematology & Coagulation Diagnostics
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAGADAC
Release Testing & Batch Certification (QC)
SECONDARYHLAAALAH
Clinical Chemistry & Hematology Diagnostics (automated analyzers, blood testing)

Keywords

  • Coagulation diagnostics
  • Hemostasis analyzers
  • Thrombin generation assays
  • Fibrinolysis ELISA kits
  • In vitro diagnostics

Where Technoclone is headquartered

Location

Headquarters

HQ city
Vienna
HQ country
Austria
HQ region
Europe

Offices2 records

Markets served

Technoclone business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Revenue model

  1. Diagnostic Tests and Reagents: Technoclone manufactures and sells diagnostic tests for coagulation and fibrinolysis including ELISA kits, latex immunoassays, and chromogenic assays. Products include D-Dimer tests, coagulation factor assays, fibrinolysis markers (t-PA, u-PA, PAI-1), and specialized tests like ADAMTS13 activity.
  2. Coagulation Instruments: Sale of automated and semi-automated coagulation analyzers (Ceveron series: s100, t100, c100, m1, m2, m4, MFU500) along with consumables, cuvettes, reagents, and accessories.
  3. OEM Products: High-quality test systems and reagents manufactured by Technoclone are sold not only under the Technoclone name worldwide but also as OEM products with major international diagnostic companies.
  4. Research Products: Sale of research-use-only products including fibrinolysis-related proteins and antibodies for research purposes.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractProduct catalogue available for download; specific pricing requires inquiry

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Technoclone product offering

Product offering

Core offering

Technoclone manufactures and sells in vitro diagnostic tests, automated and semi-automated coagulation analyzers (Ceveron series), and research-use reagents for the diagnosis and monitoring of hemostasis (blood clotting) and fibrinolysis disorders. Its product range covers routine coagulation assays, specialized thrombin generation tests, fibrinolysis ELISA panels, D-Dimer testing, and supporting auxiliary reagents, sold to clinical laboratories, hospitals, research institutions, and OEM diagnostic partners worldwide.

Product overview

Technoclone is a Vienna-based diagnostics company founded in 1987 specializing in in vitro diagnostics for hemostasis and fibrinolysis. The product portfolio centers on the Ceveron instrument family (fully automated 100 Series: c100, t100, s100; semi-automated m Series: m1, m2, m4; and MFU500 filtration unit) and a comprehensive range of diagnostic reagents and assays. The Ceveron 100 Series instruments offer fully automated coagulation testing including clotting, chromogenic, turbidimetric assays, and thrombin generation (TGA), with the s100 model additionally featuring quenching technology for automated FXIII and ADAMTS13 activity testing. The company offers Technothrombin TGA reagents for microplate readers (RUO) and Ceveron TGA Kits (CE-marked) for automated instruments. Diagnostic assays include D-Dimer testing (TECHNOLEIA), fibrinolysis panels (TECHNOZYM ELISAs for t-PA, PAI-1, u-PA, PAP Complex, Glu-Plasminogen, Protein C Inhibitor, t-PA-PAI-1 Complex), and Technochrom chromogenic assays for plasminogen and plasmin inhibitor. The portfolio also includes general and Ceveron-specific auxiliary reagents. Products are distributed globally under the Technoclone brand and as OEM products through other major diagnostic companies.

Differentiator

Problem solved

Functional benefit

Brands

  • Ceveron: Fully and semi-automated coagulation analyzers for clinical diagnostics including Ceveron s100, t100, c100, and m-series instruments
  • TECHNOZYM
  • TECHNOLEIA
  • Technochrom
  • Technothrombin TGA
  • Actibind

Products and services

  • Ceveron s100 Fully automated coagulation analyzer for clinical laboratories performing clotting, chromogenic, turbidimetric assays, TGA, and quenching assays; world's first fully automated hemostasis analyzer with quenching technology capable of automated FXIII and ADAMTS13 activity testing from a single sample.
  • Ceveron t100 Fully automated coagulation analyzer for clotting, chromogenic, turbidimetric assays, and thrombin generation testing in clinical laboratories.
  • Ceveron c100 Fully automated coagulation analyzer for clotting, chromogenic, and turbidimetric assays in clinical laboratories.
  • Ceveron m1 Semi-automated coagulation analyzer with one optical channel (620nm), for whole blood and citrate plasma samples in clinical laboratories.
  • Ceveron m2 Semi-automated coagulation analyzer with two optical channels at 405nm (UV), for citrate plasma samples in clinical laboratories.
  • Ceveron m4 Semi-automated coagulation analyzer with four optical channels at 405nm (UV), for citrate plasma samples in clinical laboratories.
  • Ceveron MFU500 Microparticle Filtration Unit (MFU) 500 enabling quick and standardized removal of microparticles from platelet poor plasma, with effectiveness comparable to ultra-centrifugation.
  • Ceveron TGA Kits CE-marked thrombin generation assay kits (RB, RC Low, RC High) optimized for Ceveron t100 and s100 instruments, measuring bleeding, thrombophilic, and anticoagulated tendencies.
  • Technothrombin TGA Research-use-only thrombin generation reagents for fluorescence microplate readers, available in kit format with multiple triggers and as modular reagents (RA, RB, RC Low, RC High, IVIG, RD, SUB).
  • TECHNOLEIA D-Dimer Latex Kit Latex-enhanced immunoassay for quantitative D-Dimer determination used in clinical laboratories for exclusion diagnosis of deep venous thrombosis, pulmonary embolism, DIC, thrombolytic treatment monitoring, and cancer diagnostics.
  • TECHNOZYM t-PA EDTA ELISA Kit Sandwich ELISA kit for quantitative determination of tissue plasminogen activator (t-PA) in human plasma, detecting both complexed and uncomplexed forms.
  • TECHNOZYM PAI-1 Antigen ELISA Kit Sandwich ELISA detecting active, latent, and t-PA-PAI-1 complex forms of plasminogen activator inhibitor-1 (PAI-1) in plasma.
  • TECHNOZYM PAI-1 Actibind ELISA Kit Highly sensitive ELISA for quantitative determination of active PAI-1 antigen in human plasma based on Actibind functional t-PA immobilization technology.
  • TECHNOZYM u-PA ELISA Kit Sandwich ELISA for quantitative determination of urokinase-type plasminogen activator (u-PA) in human plasma and tissue extracts, detecting both single and double chain urokinase.
  • TECHNOZYM u-PA Combi Actibind ELISA Kit Combined ELISA using Actibind technology for simultaneous quantitative determination of u-PA concentration and activity in human plasma.
  • TECHNOZYM PAP Complex ELISA Kit ELISA kit for determination of Plasmin-alpha-2-Antiplasmin complex (PAP) concentration in plasma, using a monoclonal antibody specific for the neoantigenic site on the complex.
  • TECHNOZYM Glu-Plasminogen ELISA Kit Sandwich ELISA for selective quantitative determination of Glu-Plasminogen in human plasma using monoclonal antibodies specific for the native Glu-form.
  • TECHNOZYM Protein C Inhibitor Actibind ELISA Kit

Companies that use Technoclone

Customer profile

Segments3 records

Ideal customer profiles3 records

Technoclone technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Technoclone partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and minor.

  • Baxter AG (former Immuno Diagnostika)coreStrategic or Co-development PartnerIn 1998, Technoclone acquired the product portfolio of the former Immuno Diagnostika from Baxter AG, enabling rapid expansion and establishment as a global diagnostics company.
  • OEM Diagnostic PartnerscoreOEM/ Whitelabel/ Licensing PartnerHigh-quality test systems and reagents manufactured by Technoclone are sold as OEM products with major international diagnostic firms, distributed under their own brand names.
  • Universities and Research ConsortiacoreStrategic or Co-development PartnerResearch and development conducted in collaboration with universities and international and national research consortia in the field of thrombosis and cardiovascular diseases.
  • ECTH (European Congress on Thrombosis and Haemostasis)minorStrategic or Co-development PartnerSince 2023, the BRB Award (Bernd R. Binder Publication Prize) has been part of the ECTH congress, bringing together researchers, scientists, clinicians, and other medical professionals for thrombosis and hemostasis education.

Scale indicators4 records

Recent moves7 records

Expansion highlights6 records

Technoclone competitors and assessment

Company assessment

Direct peers

  • Trinity Biotech: Specialty IVD company with a hemostasis product line including coagulation analyzers and reagents, comparable in scale and niche focus to Technoclone.
  • Diagnostica Stago: Privately held French company and a global leader in hemostasis diagnostics, offering automated coagulation analyzers and a comprehensive reagent menu closely overlapping Technoclone's Ceveron instruments and coagulation/fibrinolysis kits.
  • Werfen (Instrumentation Laboratory): Specialized hemostasis division (IL) with the ACL TOP family of coagulation analyzers and broad specialty reagents, directly competing with Technoclone in routine and specialty coagulation testing for clinical labs.
  • Helena Laboratories: Privately held specialty IVD company focused on hemostasis and thrombophilia testing, offering analyzers and reagents that directly compete with Technoclone's coagulation portfolio.

Emerging players

  • Enzyme Research Laboratories: Niche coagulation research reagent supplier (proteins, antibodies) with a similar customer base to Technoclone's research products and fibrinolysis research offerings.
  • Stago (OEM) / Stago reference suppliers: Reference hemostasis reagent and analyzer partners in the coagulation specialty channel, adjacent peers that overlap in the fibrinolysis, TGA, and ADAMTS13 niches Technoclone targets.

Broad incumbents

  • Roche Diagnostics: Broad incumbent with cobas t-series coagulation analyzers and reagents, competing in routine hemostasis and increasingly in specialty assays relevant to Technoclone's portfolio.
  • Siemens Healthineers (Dade Behring hemostasis): Broad incumbent with the Sysmex-derived hemostasis franchise (CA-series analyzers) and deep reagent portfolio, serving the same clinical labs as Technoclone but as part of a much wider diagnostics portfolio.
  • Sysmex: Major hematology and hemostasis analyzer vendor with a broad installed base; competes with Technoclone's Ceveron series in mid- and high-volume coagulation testing.
  • Abbott (Diagnostics): Broad incumbent with coagulation/immunoassay platforms (Architect, Alinity ci-series) that overlap with Technoclone's clinical laboratory customers and hemostasis test menu.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Technoclone social profiles

Digital presence

Technoclone compliance and trust

Trust signal

Compliance3 records

Technoclone financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Technoclone leadership team

Management profile

Number of profiles

Profiles1 record

Technoclone funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Technoclone M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Technoclone

What does Technoclone do?

Technoclone manufactures and sells in vitro diagnostic tests, automated and semi-automated coagulation analyzers (Ceveron series), and research-use reagents for the diagnosis and monitoring of hemostasis (blood clotting) and fibrinolysis disorders. Its product range covers routine coagulation assays, specialized thrombin generation tests, fibrinolysis ELISA panels, D-Dimer testing, and supporting auxiliary reagents, sold to clinical laboratories, hospitals, research institutions, and OEM diagnostic partners worldwide.

Is Technoclone a public or private company?

Technoclone is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Technoclone founded?

Technoclone was founded in 1987. It employs 11 to 50 people.

Where is Technoclone based?

Technoclone is headquartered in Vienna, Austria, in the Europe region.

How does Technoclone make money?

Four revenue lines are on record. Diagnostic Tests and Reagents are the primary driver. The others are coagulation Instruments, OEM Products and research Products.

Who are Technoclone's main competitors?

Direct peers on record are Trinity Biotech, Diagnostica Stago, Werfen (Instrumentation Laboratory) and Helena Laboratories. Emerging players are Enzyme Research Laboratories and Stago (OEM) / Stago reference suppliers. Broad incumbents are Roche Diagnostics, Siemens Healthineers (Dade Behring hemostasis), Sysmex and Abbott (Diagnostics).

Does Technoclone have an API?

No public API is recorded for Technoclone.

What industry is Technoclone in?

Technoclone's product category is Coagulation and Fibrinolysis Diagnostics. Its primary akta.pro industry code is HLAHAAAB, Hematology & Coagulation Diagnostics, with a secondary code of HLAGADAC, Release Testing & Batch Certification (QC). Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals